Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crataegus-Extract WS 1442 plus endurance training in NYHA II heart failure
2009-015005-39Phase 4Completed
- Sponsor
- Schwabe Group
- Start
- Sep 2009
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of crataegus special extract WS 1442 in heart failure (HF) (2 arms), sponsored by Schwabe Group. Primary endpoint: quality of life. Started Sep 2009; status: completed.
02
Drugs
crataegus special extract WS 1442
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2009-015005-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015005-39.